• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

market access

  1. novartis

    I truly hate my job here, they push me to spend money on lunches with doctors. I have spent THOUSANDS! Everyone is too scared to speak up! Am I alone on this?

  2. Ilumya Meeting Registration??

    Anyone hear if we are still going to meeting? My RSM says Princeton is finalizing “details” and then travel will re-open for us to book. Last email I rec’d was some people may have to come in earlier or something but rest of us would book next day? Who knows at this point. NOONE WANTS TO GO for...
    • anonymous
    • Thread
    • market access nsm sun biologics sun pharma tildra tildrakizumab
    • Replies: 9
    • Forum: Sun Pharma
Top Bottom
Back